Marker Therapeutics (MRKR) Net Equity Issued and Repurchased (2011 - 2024)
Marker Therapeutics' Net Equity Issued and Repurchased came in at $9.86 million for FY2025, down 33.9% from $14.93 million in FY2024.
Powered by 
Analysis
Marker Therapeutics (MRKR) Net Equity Issued and Repurchased (2011 - 2024) Analysis & Trends
Going back to FY2011, Marker Therapeutics' Net Equity Issued and Repurchased data covers 14 years.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
- The five-year range for annual Net Equity Issued and Repurchased is $90,477 (FY2023) to $52.55 million (FY2021).
- Per Business Quant, earlier years put Net Equity Issued and Repurchased at $14.93 million in FY2024, $90,477 in FY2023 (-55.2%), $202,130 in FY2022 (-99.6%) and $52.55 million in FY2021 (+749.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 14.89 Mn |
| Jun 30, 2024 | -12,194.00 |
| Mar 31, 2024 | 49,096.00 |
| Dec 31, 2023 | -924,163.00 |
| Sep 30, 2023 | 394,666.00 |
| Mar 31, 2023 | 619,974.00 |
| Dec 31, 2022 | 138,557.00 |
| Jun 30, 2022 | 63,573.00 |
| Jun 30, 2021 | -103,830.00 |
| Mar 31, 2021 | 52.66 Mn |
| Dec 31, 2020 | 4.00 Mn |
| Sep 30, 2020 | 1.64 Mn |
| Mar 31, 2020 | 550,000.00 |
| Sep 30, 2019 | 700,989.00 |
| Mar 31, 2019 | 57,744.00 |
| Dec 31, 2018 | 9,457.00 |
| Sep 30, 2018 | 83,086.00 |
| Jun 30, 2018 | 4.24 Mn |
| Mar 31, 2018 | 18,125.00 |
| Sep 30, 2017 | -19,043.00 |
API Access
Marker Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();